The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease.當前揭露的主題提供了使用1-去氧半乳糖野尻黴素和酶替代療法用於治療法布裡病的給藥方案和服藥日程。當前揭露的主題進一步提供了使用米加司他鹽酸鹽和阿加糖酶用於治療法布裡病的給藥方案和服藥日程。